Healthy men to test two insulin shots in Early-Stage study

This early-stage trial will compare two insulin formulations—IBI3035 and insulin icodec (Awiqli)—in 144 healthy Chinese men aged 18 to 45. Researchers will measure how the body absorbs and processes each insulin and how they affect blood sugar levels. The goal is to see if the two formulations are similar enough to be considered interchangeable, not to treat any disease.